Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab

Predicting clinical outcomes in chordoma patients receiving immunotherapy: A comparison between volumetric segmentation and RECIST

9 p | 25 | 3

Predictive equation of metastasis in patients with malignant ovarian epithelial tumors with the Ca-125 marker

5 p | 21 | 2

Predictive nomogram based on serum tumor markers and clinicopathological features for stratifying lymph node metastasis in breast cancer

11 p | 6 | 2

Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving frst-line immunotherapy: A multicenter retrospective study

21 p | 4 | 2

Nomogram predict relapse-free survival of patients with thymic epithelial tumors after surgery

11 p | 9 | 2

Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation

14 p | 4 | 1

A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: A translational research study of the Hellenic Cooperative Oncology Group (HeCOG)

10 p | 15 | 1

PPIH acts as a potential predictive biomarker for patients with common solid tumors

13 p | 1 | 1

A TP53 mutation model for the prediction of prognosis and therapeutic responses in head and neck squamous cell carcinoma

13 p | 9 | 0